Isabelle Ricard

654 total citations
19 papers, 515 citations indexed

About

Isabelle Ricard is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, Isabelle Ricard has authored 19 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Isabelle Ricard's work include Yersinia bacterium, plague, ectoparasites research (7 papers), Vector-borne infectious diseases (4 papers) and Vibrio bacteria research studies (3 papers). Isabelle Ricard is often cited by papers focused on Yersinia bacterium, plague, ectoparasites research (7 papers), Vector-borne infectious diseases (4 papers) and Vibrio bacteria research studies (3 papers). Isabelle Ricard collaborates with scholars based in France, Canada and Morocco. Isabelle Ricard's co-authors include Marcel D. Payet, Gilles Dupuis, Daniel Dive, Elizabeth Pradel, Florent Sebbane, Michaël Marceau, Jean Dessolin, Christophe Biot, Nadine Lemaître and Michel Simonet and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and European Journal of Immunology.

In The Last Decade

Isabelle Ricard

19 papers receiving 509 citations

Peers

Isabelle Ricard
Cécile Paroz Switzerland
James L. Smith United States
Micha A. Haeuptle Switzerland
Rasappa Arumugham United States
Sheena A. Linehan United Kingdom
Dinene L. Crater United States
Abdelhakim Ben Nasr United States
Cécile Paroz Switzerland
Isabelle Ricard
Citations per year, relative to Isabelle Ricard Isabelle Ricard (= 1×) peers Cécile Paroz

Countries citing papers authored by Isabelle Ricard

Since Specialization
Citations

This map shows the geographic impact of Isabelle Ricard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Ricard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Ricard more than expected).

Fields of papers citing papers by Isabelle Ricard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Ricard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Ricard. The network helps show where Isabelle Ricard may publish in the future.

Co-authorship network of co-authors of Isabelle Ricard

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Ricard. A scholar is included among the top collaborators of Isabelle Ricard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Ricard. Isabelle Ricard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ricard, Isabelle, et al.. (2020). A refined model of how Yersinia pestis produces a transmissible infection in its flea vector. PLoS Pathogens. 16(4). e1008440–e1008440. 21 indexed citations
2.
Song, Ok‐Ryul, Christophe J. Queval, Raffaella Iantomasi, et al.. (2017). Arf GAP 1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton. EMBO Reports. 19(1). 29–42. 16 indexed citations
3.
Song, Ok‐Ryul, Hanbyul Kim, Samuel Jouny, et al.. (2017). A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone. Toxins. 9(7). 227–227. 24 indexed citations
4.
Reboul, A., Nadine Lemaître, Marie Titécat, et al.. (2014). Yersinia pestis Requires the 2-Component Regulatory System OmpR-EnvZ to Resist Innate Immunity During the Early and Late Stages of Plague. The Journal of Infectious Diseases. 210(9). 1367–1375. 29 indexed citations
5.
Pradel, Elizabeth, et al.. (2014). New Insights into How Yersinia pestis Adapts to Its Mammalian Host during Bubonic Plague. PLoS Pathogens. 10(3). e1004029–e1004029. 41 indexed citations
6.
Derbise, Anne, Elizabeth Pradel, Isabelle Ricard, et al.. (2013). Inheritance of the Lysozyme Inhibitor Ivy Was an Important Evolutionary Step by Yersinia pestis to Avoid the Host Innate Immune Response. The Journal of Infectious Diseases. 207(10). 1535–1543. 20 indexed citations
7.
Lemaître, Nadine, Isabelle Ricard, Elizabeth Pradel, et al.. (2012). Efficacy of Ciprofloxacin-Gentamicin Combination Therapy in Murine Bubonic Plague. PLoS ONE. 7(12). e52503–e52503. 11 indexed citations
8.
Ricard, Isabelle, et al.. (2007). Phenotypic analysis of Yersinia pseudotuberculosis 32777 response regulator mutants: New insights into two-component system regulon plasticity in bacteria. International Journal of Medical Microbiology. 298(3-4). 193–207. 42 indexed citations
9.
Marceau, Michaël, et al.. (2007). Two-Component System Regulon Plasticity in Bacteria: A Concept Emerging from Phenotypic Analysis of Yersinia pseudotuberculosis Response Regulator Mutants. Advances in experimental medicine and biology. 603. 145–155. 10 indexed citations
10.
Biot, Christophe, Jean Dessolin, Isabelle Ricard, & Daniel Dive. (2004). Easily synthesized antimalarial ferrocene triazacyclononane quinoline conjugates. Journal of Organometallic Chemistry. 689(25). 4678–4682. 46 indexed citations
11.
Jouin, Hélène, Wassim Daher, Jamal Khalife, et al.. (2003). Double staining of Plasmodium falciparum nucleic acids with hydroethidine and thiazole orange for cell cycle stage analysis by flow cytometry. Cytometry Part A. 57A(1). 34–38. 24 indexed citations
12.
Soulère, Laurent, Patrick Delplace, Elisabeth Davioud–Charvet, et al.. (2003). Screening of Plasmodium falciparum iron superoxide dismutase inhibitors and accuracy of the SOD-assays. Bioorganic & Medicinal Chemistry. 11(23). 4941–4944. 21 indexed citations
13.
Béliveau, Richard, Denis Gingras, Erwin A. Kruger, et al.. (2002). The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.. PubMed. 8(4). 1242–50. 54 indexed citations
14.
Durand-Joly, Isabelle, Ann E. Wakefield, Robert Palmer, et al.. (2000). Ultrastructural and molecular characterization ofPneumocystis cariniiisolated from a rhesus monkey (Macaca mulatta). Medical Mycology. 38(1). 61–72. 25 indexed citations
15.
Guyard, Cyril, et al.. (1999). First steps in the purification and characterization of a Pichia anomala killer toxin.. PubMed. 46(5). 144S–144S. 6 indexed citations
16.
Aliouat, El Moukhtar, et al.. (1999). Pneumocystis carinii growth kinetics in culture systems and in hosts: involvement of each life cycle parasite stage.. PubMed. 46(5). 116S–117S. 32 indexed citations
17.
Ricard, Isabelle, Marcel D. Payet, & Gilles Dupuis. (1998). VCAM-1 is internalized by a clathrin-related pathway in human endothelial cells but its α4β1 integrin counter-receptor remains associated with the plasma membrane in human T lymphocytes. European Journal of Immunology. 28(5). 1708–1718. 42 indexed citations
18.
Ricard, Isabelle, Marcel D. Payet, & Gilles Dupuis. (1997). Clustering the adhesion molecules VLA‐4 (CD49d/CD29) in Jurkat T cells or VCAM‐1 (CD106) in endothelial (ECV 304) cells activates the phosphoinositide pathway and triggers Ca2+ mobilization. European Journal of Immunology. 27(6). 1530–1538. 40 indexed citations
19.
Dupuis, Gilles, Fawzi Aoudjit, Isabelle Ricard, & Marcel D. Payet. (1993). Effects of modulators of cytosolic Ca2+ on phytohemagglutin-dependent Ca2+ response and interleukin-2 production in Jurkat cells. Journal of Leukocyte Biology. 53(1). 66–72. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026